Trial Profile
Efficacy of cetuximab for preventing progression of CRC liver metastases after selective portal embolisation.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Nov 2011
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 13 Jul 2011 New trial record